This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The Medical College of Wisconsin, Inc., University of Virginia Patent Foundation. Active years: 2024.
Company Filing History:
1 out of 194 
1 out of 1,040 
Years Active: 2024
Title: Robyn A Oldham: Innovator in Chimeric Antigen Receptor Therapy
Introduction
Robyn A Oldham is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptor (CAR) therapy. His research focuses on developing novel effector cell types that can enhance the effectiveness of cancer treatments.
Latest Patents
Robyn A Oldham holds a patent for "T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy." This patent outlines methods for producing T-Rapa cells that can express chimeric antigen receptors. The advancements presented in this patent have the potential to improve therapeutic outcomes for patients undergoing CAR therapy.
Career Highlights
Throughout his career, Robyn has worked with esteemed institutions such as the University of Virginia Patent Foundation and The Medical College of Wisconsin, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Robyn has collaborated with notable individuals, including Daniel H Fowler and Tania Felizardo. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in advancing his research initiatives.
Conclusion
Robyn A Oldham's contributions to chimeric antigen receptor therapy exemplify the impact of innovative thinking in the medical field. His work continues to pave the way for new treatment options that could benefit countless patients.